The Global Apheresis Market Outlook 2034 reflects strong and sustained growth driven by rising demand for blood component separation, increasing prevalence of chronic and autoimmune diseases, and expanding applications of therapeutic apheresis. Valued at USD 2.9 Bn in 2023, the market is projected to reach USD 6.7 Bn by 2034, growing at a CAGR of 7.7% from 2024 to 2034. Advancements in apheresis technology, improved healthcare infrastructure, and greater adoption of plasma-based therapies are further accelerating market expansion. Additionally, growing awareness of blood donation and increasing reliance on leukapheresis in cell therapy research are contributing significantly to the market’s upward trajectory.

Apheresis is a medical procedure that separates one or more blood components from a person’s blood and returns the rest to circulation. It is also known as pheresis or hemapheresis.

Dive Deeper into Data: Get Your In-Depth Sample Now! https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=896  

Apheresis can collect stem cells, plasma, platelets, or white blood cells for medical treatment. The process involves withdrawing blood from a donor, passing it through an apparatus that uses a centrifuge to separate the blood elements, and then transfusing the remaining blood back into the donor.

Market Segmentation

By Service / Procedure Type

• Plasmapheresis: The largest segment, accounting for over 60% of the market share. Driven by the immense demand for source plasma used in fractionation to produce immunoglobulins and albumin.
• Plateletpheresis: Critical for oncology treatments and surgery; remains a steady growth segment.
• Photopheresis: The fastest-growing segment, increasingly used for treating Cutaneous T-cell Lymphoma (CTCL) and Graft-versus-Host Disease (GvHD).
• Leukapheresis & Erythrocytapheresis: Used for white blood cell and red blood cell removal/exchange, particularly in sickle cell disease management.

By Sourcing Type

• In-house Services: Hospitals and blood centers owning and operating their own equipment. This segment dominates currently due to the need for immediate access in critical care settings.
• Outsourced Services: Rapidly growing as hospitals face staffing shortages. Third-party providers bring equipment and specialized nurses to the bedside, reducing overhead for healthcare facilities.

By Application

• Neurology: High demand for treating conditions like Guillain-Barré Syndrome and Myasthenia Gravis.
• Hematology: The leading application segment due to the prevalence of blood cancers and anemia.
• Renal Diseases: Increasing use in managing conditions like Goodpasture syndrome and lupus nephritis.
• Autoimmune Disorders: A key driver for therapeutic plasma exchange (TPE).

By Industry Vertical / End User

• Hospitals & Clinics: The primary end-users for therapeutic apheresis.
• Blood Donation Centers: The major users of donor apheresis technologies for plasma and platelet collection.
• Biopharmaceutical Companies: Increasingly integrating upstream plasma sourcing into their supply chains.

By Region

• North America: Current market leader (~40% share) due to established healthcare infrastructure, high reimbursement rates, and the presence of major plasma fractionation companies.
• Europe: Strong growth driven by public healthcare mandates and aging demographics.
• Asia-Pacific: The fastest-growing region (projected highest CAGR), fueled by improving healthcare access in China and India, rising medical tourism, and government initiatives to modernize blood banking.

Regional Analysis

• North America: The US dominates the market, housing the majority of global plasma collection centers. Favorable reimbursement policies for therapeutic apheresis (e.g., Medicare coverage for TPE) sustain market revenue.
• Asia-Pacific: Rapid urbanization and the rising burden of lifestyle diseases are pushing demand. Countries like Japan have high adoption rates of novel technologies like adsorption apheresis.
• LAMEA (Latin America, Middle East, Africa): Developing infrastructure represents untapped potential, though cost remains a significant barrier to widespread adoption.

Market Drivers and Challenges

Drivers:

• Rising Chronic Disease Prevalence: The global surge in autoimmune diseases and cancer requires continuous therapeutic intervention.
• Demand for Plasma-Derived Therapies: As the need for immunoglobulins grows, so does the need for efficient plasmapheresis collection.
• Technological Advancements: Development of "smart" apheresis devices with automated interface control and data integration.

Challenges:

• High Costs: Equipment and procedure costs are prohibitive in low-to-middle-income regions.
• Shortage of Skilled Professionals: Apheresis requires specialized nursing training; global staff shortages limit service expansion.
• Donor Recruitment: "Donor fatigue" and strict eligibility criteria hamper the collection volumes required for plasma fractionation.

Market Trends

• Automation and AI: New devices feature AI algorithms to predict procedure times, optimize flow rates, and minimize donor reactions.
• Personalized Medicine: Apheresis is increasingly used to collect cells for CAR-T cell therapy and other regenerative medicines.
• Expansion to Outpatient Settings: To reduce hospital stays, therapeutic apheresis is moving towards outpatient clinics and even home-care models in some advanced markets.

Future Outlook (2035)

By 2035, the apheresis market will likely be characterized by fully automated, closed-loop systems that require minimal operator intervention. The integration of apheresis with cellular therapy manufacturing (e.g., cell collection for gene therapies) will define the high-value segment of the market. Sustainability will also emerge as a key theme, with manufacturers pushing for eco-friendly, biodegradable disposable kits.

Key Market Study Points

• Dominance of Disposables: Consumables (kits, tubing) generate recurring revenue and often outweigh equipment sales in long-term value.
• Therapeutic Shift: While donor apheresis provides volume, therapeutic apheresis provides higher value per procedure.
• Emerging Tech: Membrane filtration is gaining ground against centrifugation for specific niche applications due to its gentler handling of blood cells.

Buy this Premium Research Report:  https://www.transparencymarketresearch.com/checkout.php?rep_id=896&ltype=S

Competitive Landscape

The market is consolidated, with a few major players controlling the majority of the share:

• Terumo BCT: A global leader, particularly strong in blood component technologies and therapeutic systems (Spectra Optia).
• Fresenius Kabi: Holds a dominant position in both dialysis and apheresis, with a vast network of plasma centers.
• Haemonetics Corporation: Known for its efficiency in plasma collection devices (NexSys PCS).
• Asahi Kasei Medical: A leader in therapeutic apheresis, specifically virus removal and autoimmune treatments.
• Baxter International: A key player in acute therapies and renal care involving apheresis.

Recent Developments (2023-2025)

• Terumo BCT (Aug 2023): Received FDA clearance for a new platelet processing device, enhancing the efficiency of blood centers.
• Fresenius Kabi (2024): Expanded its disposables manufacturing capacity in the Dominican Republic to meet North American demand.
• Haemonetics (2024): continued the rollout of its NexSys PCS system with new software upgrades aimed at reducing procedure time and increasing plasma yield per donor.
• Strategic Partnerships: 2025 is expected to see increased M&A activity as major players seek to acquire smaller firms specializing in next-gen cellular collection technologies to support the booming cell & gene therapy market.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com     
Email: sales@transparencymarketresearch.com